No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

13 trials linked to this intervention

Total Trials

Recruiting

With Results

Recent Trials

Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women

NCT00628771Phase 4Completed1233 enrolled

Efficacy of Combination Therapies for Gonorrhea Treatment

NCT00926796Phase 4Completed614 enrolled

Periodical Presumptive Treatment for the Control of Gonococcal Infections Among Sex Workers

NCT01329588Phase 4Completed636 enrolled

Washington State Community Expedited Partner Treatment (EPT) Trial

NCT01665690Phase 4Completed33222 enrolled

Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men

NCT03980223Phase 4Completed641 enrolled

View all 13 trials on ClinicalTrials.gov

Research Evidence

Published studies and systematic reviews

Sort:

Serum bactericidal activity of trovafloxacin, in combination with cefepime or amikacin, in healthy volunteers.

Lubasch A, Ziege S, Brodersen B et al. · Clin Microbiol Infect · 2003

PMID: 12925107Trial

Efficacy and tolerability of once-daily oral therapy with telithromycin compared with trovafloxacin for the treatment of community-acquired pneumonia in adults.

Pullman J, Champlin J, Vrooman P S · Int J Clin Pract · 2003

PMID: 12846341Trial

Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults.

Klossek J-M, Siegert R, Nikolaidis P et al. · J Laryngol Otol · 2003

PMID: 12590855Trial

Ex vivo serum activity (killing rates) after gemifloxacin 320 mg versus trovafloxacin 200 mg single doses against ciprofloxacin-susceptible and -resistant Streptococcus pneumoniae.

Calvo A, Giménez M J, Alou L et al. · Int J Antimicrob Agents · 2002

PMID: 12297365Trial

A prospective, double-blind, multicenter study comparing clarithromycin extended-release with trovafloxacin in patients with community-acquired pneumonia.

Sokol William N, Sullivan James G, Acampora Matthew D et al. · Clin Ther · 2002

PMID: 12017405Trial

Urine bactericidal activity after administration of gemifloxacin and trovafloxacin single doses in a phase I study.

García-Calvo Gloria, Parra Araceli, Ponte Carmen et al. · Int J Antimicrob Agents · 2002

PMID: 12458147Trial

Quinolone treatment for pediatric bacterial meningitis: a comparative study of trovafloxacin and ceftriaxone with or without vancomycin.

Sáez-Llorens Xavier, McCoig Cynthia, Feris Jesús M et al. · Pediatr Infect Dis J · 2002

PMID: 11791092Trial

Influence of diminished susceptibility of Streptococcus pneumoniae to ciprofloxacin on the serum bactericidal activity of gemifloxacin and trovafloxacin after a single dose in healthy volunteers.

Prieto J, Aguilar L, Fuentes F et al. · Int J Antimicrob Agents · 2001

PMID: 11673035Trial

Effects of single oral doses of gemifloxacin (320 milligrams) versus trovafloxacin (200 milligrams) on fecal flora in healthy volunteers.

Garcia-Calvo G, Molleja A, Giménez M J et al. · Antimicrob Agents Chemother · 2001

PMID: 11158764TrialFull text (PMC)

Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: phase I study.

García-Calvo G, Parra A, Aguilar L et al. · Antimicrob Agents Chemother · 2001

PMID: 11353641TrialFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type: Substance / Medication
Fully Specified Name: Trovafloxacin (substance)
SNOMED CT: 96092008
UMLS CUI: C0379881
RxNorm CUI: 115552

Clinical Data

This intervention maps to 13 entities in the Ltrl knowledge graph.

Conditions

Biomarkers

Specialists

Symptoms

Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.